Vivanza Biosciences
VIVANZABSE

Vivanza Biosciences

₹1.810.03 (1.69%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
1.78
Today’s high
1.81
52 week low
1.74
52 week high
2.72
Open price
1.78
Previous close
1.78
Live volume
21,754
Lower circuit
1.63
Upper circuit
1.99

Fundamentals

Market Cap
₹7.12Cr
ROE
9.05%
P/E Ratio(TTM)
17.80
EPS(TTM)
0.10
P/B Ratio
1.63
Dividend Yield
0.00%
Industry P/E
33.73
Book Value
1.09
Debt to Equity
2.34
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹6.37
-85.95%
Profit (Cr)
-₹0.45
-325.00%
-406.252556.25
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+1,102%
3Y CAGR-13%
Profit growthValue
1Y (TTM)+122%

About

Vivanza Biosciences Limited is a key pharmaceutical company in India, engaged in the business of creating and distributing a variety of pharmaceutical products. Its core vision is to uncover methods for a long and healthy life, aiming to enhance the quality of life for people around the world. The company's primary operations involve research, development, manufacturing, and distribution of a wide range of pharmaceutical goods to serve healthcare needs. To navigate intense market competition, the firm concentrates on innovation, maintaining cost-efficiency, and building strategic partnerships. The company shows strong financial growth, with its reserves and surplus increasing from ₹39.79 lakhs to ₹71.53 lakhs in the past year.;
CEO/MD
Mr. Jayendra Mehta
Founded in
1982
BSE symbol
530057

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
79.98%
Promoters
20.02%
2026
7
May
Annual Result
Release date
4
May
Annual Result
Release date
12
Feb
Quarterly Result
Release date
2025
11
Nov
Quarterly Result
Release date
13
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks